CervoMed Inc (NASDAQ: CRVO) kicked off on Friday, up 3.22% from the previous trading day, before settling in for the closing price of $9.32. Over the past 52 weeks, CRVO has traded in a range of $1.80-$20.63.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 56.66% over the last five years. While this was happening, its average annual earnings per share was recorded -15.91%. With a float of $5.99 million, this company’s outstanding shares have now reached $9.25 million.
CervoMed Inc (CRVO) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of CervoMed Inc is 35.25%, while institutional ownership is 23.49%. The most recent insider transaction that took place on May 14 ’25, was worth 35,811. In this transaction CFO, GC & Secretary of this company bought 4,233 shares at a rate of $8.46, taking the stock ownership to the 5,500 shares.
CervoMed Inc (CRVO) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.55 earnings per share (EPS), lower than consensus estimate (set at -0.41) by -0.14. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.45 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -15.91% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 1.69% during the next five years compared to 56.66% growth over the previous five years of trading.
CervoMed Inc (NASDAQ: CRVO) Trading Performance Indicators
Take a look at CervoMed Inc’s (CRVO) current performance indicators. Last quarter, stock had a quick ratio of 8.16. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 11.44.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.61, a number that is poised to hit -0.65 in the next quarter and is forecasted to reach -2.09 in one year’s time.
Technical Analysis of CervoMed Inc (CRVO)
Analysing the last 5-days average volume posted by the [CervoMed Inc, CRVO], we can find that recorded value of 79420.0 was lower than the volume posted last year of 1.96 million. As of the previous 9 days, the stock’s Stochastic %D was 40.66%.
During the past 100 days, CervoMed Inc’s (CRVO) raw stochastic average was set at 54.30%, which indicates a significant increase from 34.54% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.60 in the past 14 days, which was lower than the 0.79 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.19, while its 200-day Moving Average is $6.79. Now, the first resistance to watch is $9.79. This is followed by the second major resistance level at $9.97. The third major resistance level sits at $10.19. If the price goes on to break the first support level at $9.39, it is likely to go to the next support level at $9.17. Now, if the price goes above the second support level, the third support stands at $8.99.
CervoMed Inc (NASDAQ: CRVO) Key Stats
The company with the Market Capitalisation of 89.01 million has total of 9,253K Shares Outstanding. Its annual sales at the moment are 9,740 K in contrast with the sum of -16,290 K annual income. Company’s last quarter sales were recorded 1,760 K and last quarter income was -6,260 K.
